Skip to main content
. Author manuscript; available in PMC: 2023 Mar 8.
Published in final edited form as: J Health Commun. 2022 Mar 8;27(2):69–83. doi: 10.1080/10810730.2022.2044413

Table 1:

Keyword terms used for searches

1. (Women OR woman OR female)
 AND
2. (eHealth OR mHealth OR “digital health” OR mobile OR SMS OR “short message” OR “text message” OR texting OR tablet OR app OR “social media” OR facebook OR twitter OR smartphone OR “mobile applications” OR “mobile application”)
 AND
3. (“family planning” OR contracept* OR condom OR condoms OR IUD OR “intrauterine device” OR LARC OR “contraceptive implant” OR “etonogestrel implant” OR “injectable contraception” OR “injectable contraceptive” OR DMPA OR Depo OR “oral contraceptive pill” OR NuvaRing OR OrthoEvra OR Paragard OR Mirena OR Skyla OR Liletta OR Implanon OR Nexplanon)
4. In addition, the following MeSH terms were used for the PubMed search:
 (Telemedicine OR Cell Phone OR Text messaging OR Reminder Systems OR Social Media OR Smartphone OR Mobile Applications)
 AND
 (Family Planning Services OR Contraception OR Contraceptive Agents OR Contraceptive Devices).

Note: While the same search terms were used across databases, there was some variability in the search fields. For PubMed and Embase, the search terms were limited to the title or abstract; for SCOPUS, the search included title, abstract, and keyword; for Web of Science, the topic search was used; for GenderWatch, the search included anywhere but the full text (i.e. title or abstract); and the search in Women’s Studies International searched the full text for the search terms.